LENZ THERAPEUTICS INC (LENZ) Stock Earnings & Estimates
USA - NASDAQ:LENZ - US52635N1037 - Common Stock
25.6 USD
-0.89 (-3.36%)
25.6 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 285.82% | N/A 165.75% | N/A 67.82% | N/A 56.10% | N/A 29.91% | N/A 16.69% | N/A 13.14% | |||||||
| EBITDA YoY % growth | -30K | -13.38M -44,500.00% | -59.71M -346.26% | -103.29M -72.99% | -70.703M 31.55% | -58.552M 17.19% | N/A -34.96% | N/A 8.94% | N/A 102.58% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -30K | -13.5M -44,900.00% | -60.44M -347.70% | -105.64M -74.78% | -73.11M 30.79% | -58.61M 19.83% | N/A -42.55% | N/A 5.98% | N/A 88.88% | N/A 677.68% | N/A 203.13% | N/A 60.60% | N/A 25.38% | N/A 19.15% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.85 86.13% | -12.75 -589.19% | -4.77 62.59% | N/A 43.83% | N/A 2.68% | N/A 91.71% | N/A 1,094.52% | N/A 129.27% | N/A 36.23% | N/A 8.36% | N/A -3.23% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.94 -103.46% | -0.92 -73.69% | -0.72 -40.67% | -0.46 22.78% | -0.40 56.77% | -0.28 69.53% | -0.10 85.78% | 0.05 110.07% | 0.19 147.90% |
| Revenue Q2Q % growth | 5.705M | 3.749M | 7.65M 53.00% | 16.184M 29.47% | 18.734M 228.38% | 21.624M 476.79% | 27.642M 261.33% | 33.456M 106.72% | 39.372M 110.16% |
| EBITDA Q2Q % growth | -27.165M -79.11% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -31.708M -108.26% | -29.788M -75.94% | -23.154M -37.36% | -11.22M 49.80% | -11.73M 63.01% | -11.016M 63.02% | -6.018M 74.01% | -1.326M 88.18% | 3.366M 128.70% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.59 -55.26% | -0.72 | 0.13 | 18.10% |
| Q2 2025 Q2Q % growth | -0.51 -27.50% | -0.62 | 0.11 | 18.05% |
| Q1 2025 Q2Q % growth | -0.53 84.99% | -0.56 | 0.03 | 6.09% |
| Q4 2024 Q2Q % growth | -0.46 83.57% | -0.42 | -0.04 | -9.11% |
| Q3 2024 Q2Q % growth | -0.38 86.08% | -0.47 | 0.09 | 19.83% |
| Q2 2024 Q2Q % growth | -0.40 94.11% | -0.50 | 0.10 | 19.61% |
| Q1 2024 Q2Q % growth | -3.53 -720.93% | -0.86 | -2.67 | -311.18% |
| Q4 2023 Q2Q % growth | -2.80 -536.36% | -0.92 | -1.88 | -204.00% |
| Q3 2023 Q2Q % growth | -2.73 -506.67% | -1.80 | -0.93 | -52.03% |
| Q2 2023 Q2Q % growth | -6.79 -1,314.58% | -2.19 | -4.60 | -209.77% |
| Q1 2023 Q2Q % growth | -0.43 10.42% | -0.34 | -0.09 | -27.10% |
| Q4 2022 Q2Q % growth | -0.44 -25.71% | -0.50 | 0.06 | 12.56% |
| Q3 2022 Q2Q % growth | -0.45 -60.71% | -0.47 | 0.02 | 3.85% |
| Q2 2022 Q2Q % growth | -0.48 86.09% | -0.50 | 0.02 | 4.31% |
| Q1 2022 Q2Q % growth | -0.48 | -0.40 | -0.08 | -20.66% |
| Q4 2021 Q2Q % growth | -0.35 | -0.30 | -0.05 | -15.34% |
| Q3 2021 Q2Q % growth | -0.28 | -0.28 | 0.00 | 0.78% |
| Q2 2021 Q2Q % growth | -3.45 | -1.13 | -2.32 | -206.10% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 12.5M | 6.965M | 5.535M | 79.47% |
| Q3 2023 Q2Q % growth | 1.53M | -1.53M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.8% | 0.24% | 7.86% |
| Revenue | 0% | -2.85% | 0% | 68.02% |